We serve Chemical Name:(2R,4R)-4-Methylpiperidine-2-carboxylic acid CAS:74892-81-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2R,4R)-4-Methylpiperidine-2-carboxylic acid
CAS.NO:74892-81-2
Synonyms:(2r,4r)-4-methylpipecolinic acid;(2R,4R)-4-Methyl-2-piperidinecarboxylate;ARGATROBAN INTER-1;(2R,4R)-4-methylpiperidinecarboxylic acid;(2R,4R)-4-methyl-2-piperidinecarboxylic acid;(2R,4R)-4-methylpipecolic acid;(2R-trans)-4-Methyl-2-piperidinecarboxylic acid;2-piperidinecarboxylic acid,4-methyl-,(2r,4r);(2r,4r)-4-methyl-2-pipecolic acid
Molecular Formula:C7H13NO2
Molecular Weight:143.18400
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:267ºC
Density:1.062
Index of Refraction:1.464
PSA:49.33000
Exact Mass:143.09500
LogP:0.78790
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2r,4r)-4-methylpipecolinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2r,4r)-4-methyl-2-pipecolic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ARGATROBAN INTER-1 Use and application,(2R,4R)-4-methylpipecolic acid technical grade,usp/ep/jp grade.
Related News: In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better. (2R,4R)-4-Methylpiperidine-2-carboxylic acid manufacturer With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. (2R,4R)-4-Methylpiperidine-2-carboxylic acid supplier The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. (2R,4R)-4-Methylpiperidine-2-carboxylic acid vendor In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better. (2R,4R)-4-Methylpiperidine-2-carboxylic acid factory When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau.
